Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed

Objective: To evaluate the efficacy and safety of monotherapy with adalimumab in patients with RA for whom previous DMARD treatment has failed. Methods: In a 26 week, double blind, placebo controlled, phase III trial, 544 patients with RA were randomised to monotherapy with adalimumab 20 mg every ot...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: van de Putte, L B A, Atkins, C, Malaise, M, Sany, J, Russell, A, van Riel, P L C M, Settas, L, Bijlsma, J, Todesco, S, Dougados, M, Nash, P, Emery, P, Walter, N, Kaul, M, Fischkoff, S, Kupper, H
Formato: Artigo
Idioma:Inglês
Publicado em: 2004
Assuntos:
Extended Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1755008/
https://ncbi.nlm.nih.gov/pubmed/15082480
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2003.013052
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados